Vivos Therapeutics Inc VVOS
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-11 |
| Shares Out. | 13,890,000 |
| Website | vivos.com/ โ |
| Phone | 13026587581 |
| Employees | 268 |
| Revenue | $5.1M |
| Gross Profit | $3.1M |
| Net Income | -$7.8M |
| Free Cash Flow | -$19.7M |
| Total Assets | $25.0M |
| Total Liabilities | $26.3M |
| Equity | -$1.3M |
About Vivos Therapeutics Inc
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Vivos Therapeutics Inc is a publicly traded company under the ticker symbol VVOS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
9 analysts (2026-07-01)

